Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach
Completed · Not applicable
Conditions studied: Cancer, Tobacco Dependence, Tobacco Use Cessation
In brief
This is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR) delivering cancer-targeted educational messages to support referral to smoking cessation resources for patients with cancer.
Key facts
- Study ID
- NCT05829824
- Run by
- University of California, San Francisco
- People needed
- 400
- Starts
- 2023-11-27
- Expected to finish
- 2025-08-15
- Last updated by the study team
- 2026-02-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18 years and older.
- Able to understand study procedures and to comply with them for the entire length of the study.
- Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.
- English, Spanish, Cantonese, or Mandarin speaking.
- Self-reported current use of tobacco, including e-cigarette on EHR.
- Has a diagnosis of cancer.
- Has been seen by a prescribing provider within a UCSF Cancer Center-affiliated clinical department within the past 3 months.
You may not qualify if…
- Contraindication to any study-related procedure or assessment.
- No valid contact telephone number.
- Currently hospitalized or having been discharged from inpatient setting within the past month (according to EHR).
Where it is running
- University of California, San Francisco — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.